We are live on ! Find out more
IRAG

Investment Research & Advisory Group Portfolio holdings

AUM $324M
1-Year Est. Return 22.57%
This Fund
S&P 500
This Quarter Est. Return
+8.68%
1 Year Est. Return
+22.57%
3 Year Est. Return
+88.65%
5 Year Est. Return
+107.32%
10 Year Est. Return
AUM
$152M
AUM Growth
+$15.6M
Cap. Flow
+$15.3M
Cap. Flow %
10.11%
Top 10 Hldgs %
53.32%
Holding
183
New
42
Increased
46
Reduced
18
Closed
7

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.3M
2
MA icon
Mastercard
MA
+$153K
3
TSM icon
TSMC
TSM
+$111K
4
PG icon
Procter & Gamble
PG
+$98.8K
5
MCK icon
McKesson
MCK
+$97K

Sector Composition

Rank Sector Weight
1 Financials 19.88%
2 Technology 16.61%
3 Consumer Discretionary 10.76%
4 Healthcare 9.39%
5 Communication Services 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJH icon
51
iShares Core S&P Mid-Cap ETF
IJH
$127B
$306K 0.2%
5,690
+445
+8% +$24K
BBJP icon
52
JPMorgan BetaBuilders Japan ETF
BBJP
$18.9B
$304K 0.2%
+5,375
New +$306K
VDE icon
53
Vanguard Energy ETF
VDE
$9.84B
$301K 0.2%
3,965
IWB icon
54
iShares Russell 1000 ETF
IWB
$50.2B
$285K 0.19%
1,179
-266
-18% -$62.7K
AMT icon
55
American Tower
AMT
$80.4B
$267K 0.18%
988
SCHO icon
56
Schwab Short-Term US Treasury ETF
SCHO
$12.9B
$266K 0.18%
+10,398
New +$267K
SNPS icon
57
Synopsys
SNPS
$79.7B
$251K 0.17%
5,717
BNDX icon
58
Vanguard Total International Bond ETF
BNDX
$83.1B
$220K 0.15%
3,849
+2,614
+212% +$149K
LOW icon
59
Lowe's Companies
LOW
$125B
$220K 0.15%
1,132
NVS icon
60
Novartis
NVS
$297B
$220K 0.15%
2,413
-14,575
-86% -$1.3M
TFC icon
61
Truist Financial
TFC
$64B
$209K 0.14%
3,757
-438
-10% -$25.7K
PANW icon
62
Palo Alto Networks
PANW
$297B
$202K 0.13%
3,264
MRK icon
63
Merck
MRK
$318B
$195K 0.13%
2,503
-77
-3% -$5.73K
HON icon
64
Honeywell
HON
$78B
$193K 0.13%
936
IJR icon
65
iShares Core S&P Small-Cap ETF
IJR
$112B
$190K 0.13%
1,685
+180
+12% +$20.1K
VTI icon
66
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$177K 0.12%
796
MINT icon
67
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
$168K 0.11%
1,649
IJT icon
68
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.41B
$166K 0.11%
1,252
-48
-4% -$6.25K
IEI icon
69
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
$162K 0.11%
+1,243
New +$162K
IVV icon
70
iShares Core S&P 500 ETF
IVV
$904B
$152K 0.1%
354
SDY icon
71
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$150K 0.1%
1,227
AMGN icon
72
Amgen
AMGN
$222B
$147K 0.1%
604
IJS icon
73
iShares S&P Small-Cap 600 Value ETF
IJS
$8.37B
$136K 0.09%
1,294
ABBV icon
74
AbbVie
ABBV
$435B
$134K 0.09%
1,193
IEMG icon
75
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$125K 0.08%
1,866
+1,796
+2,566% +$118K

Similar funds

Investment Research & Advisory Group's Q2 2021 Portfolio in Review

As of Q2 2021, Investment Research & Advisory Group held 183 positions worth $152M, up 11% from $136M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Investment Research & Advisory Group deployed $15.3M of net new capital in Q2 2021, opening 42 new positions and adding to 46 existing holdings. Its largest new stake was iShares S&P 500 Growth ETF: 10,164 shares worth $739K.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Novartis, an estimated $1.3M trimmed.

  • Investment Research & Advisory Group's largest Q2 2021 buy was iShares S&P 500 Growth ETF: 10,164 shares worth $739K.
  • Investment Research & Advisory Group added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $12.3M increase.
  • Investment Research & Advisory Group's biggest Q2 2021 reduction was Novartis, cutting an estimated $1.3M.
  • Investment Research & Advisory Group fully exited McKesson in Q2 2021, selling an estimated $97K.
  • Investment Research & Advisory Group's ten largest holdings make up 53% of its $152M portfolio in Q2 2021.
  • Investment Research & Advisory Group opened 42 new positions and closed 7 in Q2 2021.
  • Investment Research & Advisory Group's portfolio value rose 11% quarter-over-quarter to $152M.

Based on Investment Research & Advisory Group's 13F filing for Q2 2021, filed 29 Jul 2021.